On May 1, 2026, Purdue Pharma permanently ceased operations. Knoa Pharma, a new and different company, will distribute medicines formerly distributed by Purdue Pharma. For inquiries about a Knoa Pharma or Purdue Pharma medicine, or to report an adverse event or product complaint, click here.
Logo Logo Logo Logo Logo
  • About Us
    • Who We Are
    • Ethics & Compliance
    • Operating Injunction
    • Careers
    • News & Media
    • Contact Us
  • Patients & Caregivers
    • Medicines from Knoa Pharma
    • Ask Knoa Medical
    • Responsible Use of Opioids
    • Safe Disposal of Opioids
  • Healthcare Professionals
    • Medicines from Knoa Pharma
    • Ask Knoa Medical
    • Responsible Use of Opioids
    • Clinical Trials
    • Research
    • Partner with Knoa Pharma
  • Public Health Initiatives
    • Public Health Initiatives
    • Expanding Access to Opioid Use Disorder Treatment
    • Advancing Overdose Treatment Options
    • Research
    • Impact Reporting
  • Science
    • Pipeline
    • Scientific Publications
      • Tinostamustine
      • Sunobinop
    • Partnering with Knoa Pharma
  • About Us
    • Who We Are
    • Ethics & Compliance
    • Operating Injunction
    • Careers
    • News & Media
    • Contact Us
  • Patients & Caregivers
    • Medicines from Knoa Pharma
    • Ask Knoa Medical
    • Responsible Use of Opioids
    • Safe Disposal of Opioids
  • Healthcare Professionals
    • Medicines from Knoa Pharma
    • Ask Knoa Medical
    • Responsible Use of Opioids
    • Clinical Trials
    • Research
    • Partner with Knoa Pharma
  • Public Health Initiatives
    • Public Health Initiatives
    • Expanding Access to Opioid Use Disorder Treatment
    • Advancing Overdose Treatment Options
    • Research
    • Impact Reporting
  • Science
    • Pipeline
    • Scientific Publications

      • Tinostamustine
      • Sunobinop
    • Partnering with Knoa Pharma

Knoa Pharma Begins Operations as a New, Public Health-Focused Company Dedicated to Supporting Patients and Abating the Opioid Crisis

May 1, 2026 | News
New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations 
Read More
Recent Posts
  • Knoa Pharma Board Appoints Michael Goettler as President and Chief Executive Officer
  • Knoa Pharma and GCAR Announce First Newly Diagnosed Glioblastoma Patient Randomized in Phase 2/3 GBM AGILE Evaluation of Tinostamustine and First Recurrent Patient Dosed
  • Knoa Pharma to Present Pipeline Assets at BIO International Convention 2026
  • Knoa Pharma Begins Operations as a New, Public Health-Focused Company Dedicated to Supporting Patients and Abating the Opioid Crisis
Archives
  • July 2026
  • June 2026
  • May 2026

About Us
  • Who We Are
  • Ethics & Compliance
  • Operating Injunction
  • Careers
  • Contact Us

Patient-Focused
  • Patients & Caregivers
  • Medicines from Knoa Pharma
  • Report an Adverse Event or Product Complaint
Healthcare
Professionals
  • Healthcare Professionals
  • Medicines from Knoa Pharma
  • Partner with Knoa Pharma
  • Ask Knoa Medical
Public Health Initiatives
  • Public Health Initiatives
  • Expanding Access to Opioid Use Disorder Treatment
  • Advancing Overdose Treatment Options
  • Research
  • Impact Reporting

News
  • Press Releases
  • Media Contact

Legal
  • Terms & Conditions
  • Privacy Policy/Data Rights Request
  • Do Not Sell My Information
© Knoa Pharma, as used in this site, refers to Knoa Pharma LLC and its subsidiaries, which include Rhodes Pharmaceuticals LLC, Knoa Pharmaceutical Products LLC, and Knoa Pharmaceuticals LLC.
Accessibility Adjustments

Powered by OneTap

Accessibility Commitment for Knoa Pharma LLC

At Knoa Pharma, we are committed to making our digital presence as accessible and inclusive as reasonably possible for all users, including individuals with disabilities. Our goal is to improve the usability of https://www.knoapharma.com and to support a more accessible experience for everyone, regardless of their abilities or the technologies they use.

Our Approach to Accessibility

We aim to align with the Web Content Accessibility Guidelines (WCAG), which define internationally recognized standards for digital accessibility. While full compliance cannot always be guaranteed, we strive to implement improvements where feasible and regularly review accessibility-related aspects of our website. Accessibility is an ongoing process, and we are committed to improving the experience over time as technologies, standards, and user needs evolve.

Accessibility Features

To support accessibility, https://www.knoapharma.com may utilize tools such as the OneTap accessibility toolbar. This interface provides users with a range of helpful features, including:
  • Adjustable text size and contrast settings
  • Highlighting of links and text for better visibility
  • Full keyboard navigation of the toolbar interface
  • Quick launch via keyboard shortcut: Alt + . (Windows) or ⌘ + . (Mac)
Please note the following:
  • The availability and effectiveness of these features depend on the website's configuration and ongoing maintenance.
  • While we strive to ensure accessibility, we cannot guarantee that every part of https://www.knoapharma.com will be fully accessible at all times. Some content may be provided by third parties or affected by technical constraints beyond our immediate control.

Feedback and Contact

We welcome your feedback. If you experience any accessibility barriers or have suggestions for improvement, please contact us. We are committed to reviewing all inquiries and aim to respond within 3–5 business days. If you require assistance accessing any part of this website, we are happy to provide support through alternative channels upon request. Last updated: May 1, 2026
How long do you want to hide the toolbar?
Hide Toolbar Duration
Select your accessibility profile
Vision Impaired Mode
Enhances website's visuals
Seizure Safe Profile
Clear flashes & reduces color
ADHD Friendly Mode
Focused browsing, distraction-free
Blindness Mode
Reduces distractions, improves focus
Epilepsy Safe Mode
Dims colors and stops blinking
Content Modules
Font Size

Default

Line Height

Default

Color Modules
Orientation Modules
×

Privacy Policy Updates

Please read carefully the Knoa Pharma LLC Privacy Policy (the “Privacy Policy”), which is part of the Knoa Pharma LLC Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parties’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through your use of the Service, how we use it, how we share it, how we protect it, and the choices you can make about your information.